We are live on ! Find out more
HA

Homestead Advisers Portfolio holdings

AUM $3.72B
1-Year Est. Return 24.04%
This Fund
S&P 500
This Quarter Est. Return
+18.45%
1 Year Est. Return
+24.04%
3 Year Est. Return
+73.21%
5 Year Est. Return
+100.2%
10 Year Est. Return
+356.14%
AUM
$3.89B
AUM Growth
+$500M
Cap. Flow
-$43.9M
Cap. Flow %
-1.13%
Top 10 Hldgs %
38.62%
Holding
104
New
8
Increased
39
Reduced
52
Closed
5

Top Buys

Rank Stock Value
1
ULTA icon
Ulta Beauty
ULTA
+$38M
2
HD icon
Home Depot
HD
+$37.2M
3
TJX icon
TJX Companies
TJX
+$27.1M
4
ABBV icon
AbbVie
ABBV
+$26.7M
5
ETN icon
Eaton
ETN
+$17.6M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$61.9M
2
GPC icon
Genuine Parts
GPC
+$58.7M
3
V icon
Visa
V
+$37.8M
4
PH icon
Parker-Hannifin
PH
+$22.3M
5
MSFT icon
Microsoft
MSFT
+$16.7M

Sector Composition

Rank Sector Weight
1 Healthcare 22.57%
2 Financials 21.83%
3 Technology 16.15%
4 Industrials 13.74%
5 Consumer Discretionary 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.84T
$217M 5.58%
1,067,787
-92,089
-8% -$16.7M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.9T
$183M 4.69%
2,583,660
-102,000
-4% -$6.88M
V icon
3
Visa
V
$677B
$154M 3.97%
799,374
-207,000
-21% -$37.8M
AVY icon
4
Avery Dennison
AVY
$12.3B
$152M 3.9%
1,329,758
-62,515
-4% -$6.87M
NVDA icon
5
NVIDIA
NVDA
$5.01T
$143M 3.67%
15,035,520
-12,000
-0.1% -$97.1K
HON icon
6
Honeywell
HON
$77.1B
$139M 3.56%
1,016,762
+1,167
+0.1% +$154K
ABT icon
7
Abbott
ABT
$180B
$138M 3.55%
1,509,646
+1,000
+0.1% +$90.4K
ALL icon
8
Allstate
ALL
$66.9B
$138M 3.54%
1,419,198
+2,000
+0.1% +$197K
JPM icon
9
JPMorgan Chase
JPM
$939B
$137M 3.51%
1,454,236
+2,000
+0.1% +$190K
PFE icon
10
Pfizer
PFE
$140B
$104M 2.66%
3,337,554
+3,056
+0.1% +$104K
MRK icon
11
Merck
MRK
$324B
$100M 2.57%
1,357,793
+734
+0.1% +$55.3K
PH icon
12
Parker-Hannifin
PH
$125B
$98.4M 2.53%
536,880
-138,295
-20% -$22.3M
CVX icon
13
Chevron
CVX
$388B
$91.1M 2.34%
1,021,023
+1,600
+0.2% +$143K
CNC icon
14
Centene
CNC
$31.3B
$88.9M 2.28%
1,398,636
+1,900
+0.1% +$124K
VMW
15
DELISTED
VMware, Inc
VMW
$81.4M 2.09%
525,340
+600
+0.1% +$82.5K
CB icon
16
Chubb
CB
$140B
$77M 1.98%
608,211
+1,600
+0.3% +$185K
ABBV icon
17
AbbVie
ABBV
$458B
$75.5M 1.94%
768,860
+303,498
+65% +$26.7M
NXPI icon
18
NXP Semiconductors
NXPI
$68B
$74.5M 1.91%
653,003
+900
+0.1% +$90K
CI icon
19
Cigna
CI
$76.6B
$73M 1.87%
388,962
+400
+0.1% +$75.9K
BAC icon
20
Bank of America
BAC
$435B
$72.7M 1.87%
3,059,535
+4,600
+0.2% +$109K
LDOS icon
21
Leidos
LDOS
$14.1B
$72.2M 1.86%
771,196
+12,100
+2% +$1.19M
GS icon
22
Goldman Sachs
GS
$313B
$70.1M 1.8%
354,636
+400
+0.1% +$75.1K
MDT icon
23
Medtronic
MDT
$107B
$69.9M 1.8%
762,140
+800
+0.1% +$76.7K
BMY icon
24
Bristol-Myers Squibb
BMY
$127B
$69.7M 1.79%
1,184,989
+1,600
+0.1% +$95.7K
CSX icon
25
CSX Corp
CSX
$98.6B
$68.4M 1.76%
2,942,133
+651,300
+28% +$14.4M

Similar funds

Homestead Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Homestead Advisers held 104 positions worth $3.89B, up 15% from $3.39B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Homestead Advisers's Q2 2020 filing shows 8 new, 39 increased, 52 reduced and 5 closed positions. Its largest new stake was Ulta Beauty: 176,772 shares worth $36M. The largest sale was Allergan plc, an estimated $61.9M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Financials and Technology.

  • Homestead Advisers's largest Q2 2020 buy was Ulta Beauty: 176,772 shares worth $36M.
  • Homestead Advisers added most to AbbVie in Q2 2020, an estimated $26.7M increase.
  • Homestead Advisers's biggest Q2 2020 reduction was Visa, cutting an estimated $37.8M.
  • Homestead Advisers fully exited Allergan plc in Q2 2020, selling an estimated $61.9M.
  • Homestead Advisers's ten largest holdings make up 39% of its $3.89B portfolio in Q2 2020.
  • Homestead Advisers opened 8 new positions and closed 5 in Q2 2020.
  • Homestead Advisers's portfolio value rose 15% quarter-over-quarter to $3.89B.

Based on Homestead Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.